Is Pazle lasting nasal spray (active ingredient unknown) safe to use during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Safety of Pazle Lasting Nasal Spray During Pregnancy

Modern nasal corticosteroid sprays, including those containing fluticasone, mometasone, and budesonide, are safe to use during pregnancy at recommended doses and can be continued throughout pregnancy for rhinitis or chronic rhinosinusitis management. 1

Understanding Nasal Sprays in Pregnancy

Since the active ingredient of "Pazle lasting nasal spray" is not specified, we need to consider the most common types of nasal sprays and their safety profiles during pregnancy:

Intranasal Corticosteroids (Most Likely Component)

  • Most intranasal corticosteroids are FDA Pregnancy Category C, but gestational risk has not been confirmed in observational human data 2
  • A meta-analysis concluded that intranasal corticosteroids during pregnancy do not increase risks of:
    • Major malformations
    • Preterm delivery
    • Low birth weight
    • Pregnancy-induced hypertension 2

Safety Profiles of Specific Nasal Corticosteroids

  • Budesonide: FDA Pregnancy Category B (safest option) with extensive human safety data 2
  • Fluticasone and Mometasone: Have reassuring safety profiles and can be used during pregnancy 1, 3
  • Beclomethasone: Has accumulated safety data from human use 2
  • Triamcinolone: Has been associated with respiratory tract defects and should be avoided 3

Recommendations for Use

If Pazle contains a nasal corticosteroid:

  • Continue using if it has adequately controlled symptoms before pregnancy 2
  • Use at the lowest effective dose 2
  • If starting treatment during pregnancy, budesonide is preferred (Category B) 2

What to Avoid During Pregnancy

  • Oral decongestants: Should be avoided, especially during the first trimester, due to reports of association with congenital malformations such as gastroschisis and small intestinal atresia 2
  • Intranasal decongestants: Safety during pregnancy has not been well studied 2
  • Off-label formulations: Budesonide irrigations or corticosteroid nasal drops are not recommended during pregnancy 2

Alternative Safe Options

If Pazle is not a corticosteroid or if you need alternatives:

  • Sodium cromolyn: Pregnancy Category B and safe for allergic rhinitis in pregnancy 2
  • Montelukast: Pregnancy Category B with reassuring animal reproductive studies 2

Clinical Decision Making

  1. If Pazle contains a corticosteroid: Continue at recommended dose if symptoms are controlled
  2. If unsure of contents: Consider switching to budesonide nasal spray (safest option)
  3. If symptoms are severe: Consult with both an allergist and obstetrician before making changes

Important Caveats

  • The risk of undertreated rhinitis or sinusitis affecting quality of life and sleep may indirectly impact pregnancy outcomes 1
  • During pregnancy, it is advised to continue nasal corticosteroid sprays for chronic rhinosinusitis maintenance 2
  • Always use medications at the lowest effective dose during pregnancy 2

Remember to consult with your healthcare provider to confirm the active ingredient in Pazle nasal spray and to ensure it's appropriate for your specific situation during pregnancy.

References

Guideline

Management of Rhinitis and Chronic Rhinosinusitis in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Safety of intranasal corticosteroid sprays during pregnancy: an updated review.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.